Predictors of left main or three-vessel disease in patients who have acute coronary syndromes with non-ST-segment
Masami Kosuge1, Kazuo Kimura, Toshiyuki Ishikawa
1The Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Insights
ST-segment elevation in lead aVR (>0.5 mm) and positive troponin T are early, noninvasive predictors of left main or 3-vessel disease in acute coronary syndromes. These findings aid in identifying high-risk patients early.
Area of Science:
- Cardiology
- Diagnostic Medicine
- Emergency Medicine
Background:
- Left main (LM) or 3-vessel disease (3-VD) are critical coronary artery pathologies.
- Early identification of LM/3-VD in acute coronary syndromes (ACS) is crucial for timely intervention.
- Noninvasive predictors for LM/3-VD in non-ST-segment elevation ACS (NSTEME-ACS) are needed.
Purpose of the Study:
- To identify simple, noninvasive early predictors of LM/3-VD in patients with NSTEME-ACS.
- To evaluate the predictive value of clinical variables on admission for LM/3-VD.
Main Methods:
- Retrospective study of 310 NSTEME-ACS patients.
- Analysis of clinical variables on admission.
- Univariate and multivariate logistic regression to identify predictors of LM/3-VD.
Main Results:
- ST-segment elevation in lead aVR of ≥0.5 mm was the strongest predictor (OR 19.7, p<0.001).
- Positive troponin T was also a significant predictor (OR 3.08, p=0.048).
- ST-segment elevation in lead aVR demonstrated high sensitivity (78%) and specificity (86%) for LM/3-VD.
Conclusions:
- ST-segment elevation in lead aVR (≥0.5 mm) and positive troponin T are valuable early predictors of LM/3-VD in NSTEME-ACS.
- ST-segment elevation in lead aVR is a particularly strong and useful predictor.
- These findings can aid in risk stratification and management decisions for NSTEME-ACS patients.
Abstract:
To identify an early, simple, noninvasive predictor of left main (LM) or 3-vessel disease (3-VD), we retrospectively studied clinical variables on admission in 310 patients with acute coronary syndromes with non-ST-segment elevation. Univariate analysis indicated that many factors were related to LM/3-VD. Multivariate analysis showed that ST-segment elevation in lead aVR of >/=0.5 mm was the strongest predictor of LM/3-VD, followed by positive troponin T (odds ratio 19.7, p <0.001, and odds ratio 3.08, p = 0.048, respectively). ST-segment elevation in lead aVR of >/=0.5 mm and positive troponin T identified LM/3-VD with sensitivities of 78% and 62%, specificities of 86% and 59%, positive predictive values of 57% and 26%, and negative predictive values of 95% and 87%, respectively (p <0.05). Our findings suggest that in patients with non-ST-segment elevation acute coronary syndromes, ST-segment elevation in lead aVR of >/=0.5 mm and positive troponin T on admission (especially the former) are useful predictors of LM/3-VD.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Angina III: Clinical Manifestations and Assessment
